Literature DB >> 14562412

Role of activation-induced cell death in pathogenesis of patients with chronic hepatitis B.

Chun-Sheng Hou1, Gui-Qiang Wang, Shu-Lan Lu, Bei Yue, Ming-Rong Li, Xiao-Yan Wang, Jian-Wu Yu.   

Abstract

AIM: To study and compare the difference of activation-induced cell death (AICD) in peripheral blood T-lymphocytes(PBL-Ts) from patients with chronic hepatitis B (CHB) and the normal people in vitro, and to explore the role of AICD in chronic hepatitis B virus (HBV) infection and the pathogenesis of CHB.
METHODS: Twenty-five patients and fourteen healthy people were selected for isolation of PBL-Ts. During cultivation, anti-CD3 mAb, PMA and ionomycin were used for AICD of PBL-Ts. AICD ratio of PBL-Ts was detected with TdT-mediated dUTP nick end labeling and assessed by flow cytometry.
RESULTS: When induced with anti-CD3, PMA and ionomycin in vitro, AICD ratio of PBL-Ts from CHB patients was significantly higher than that from healthy control (17.24+/-1.21 vs. 6.63+/-1.00, P<0.01) and that from CHB patients without induction (17.24+/-1.21 vs. 9.88+/-1.36, P<0.01). There was a similar AICD ratio of PBL-Ts between induction group and without induction group, but no difference was found before and after induction in healthy control. The density of INF-gamma in culture media of induction groups of CHB was lower than that of other groups (P<0.01). There was no difference between these groups in density of IL-10 (P>0.05).
CONCLUSION: When induced during cultivation in vitro, PBL-Ts from CHB have AICD very commonly. This phenomenon has a potentially important relation with pathogenesis of CHB and chronicity of HBV infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14562412      PMCID: PMC4656497          DOI: 10.3748/wjg.v9.i10.2356

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  14 in total

1.  Primed T cells are more resistant to Fas-mediated activation-induced cell death than naive T cells.

Authors:  M Inaba; K Kurasawa; M Mamura; K Kumano; Y Saito; I Iwamoto
Journal:  J Immunol       Date:  1999-08-01       Impact factor: 5.422

Review 2.  Antigen-induced T cell death is regulated by CD4 expression.

Authors:  A R Hamad; J P Schneck
Journal:  Int Rev Immunol       Date:  2001-10       Impact factor: 5.311

3.  CTLA-4 blockade of antigen-induced cell death.

Authors:  S da Rocha Dias; C E Rudd
Journal:  Blood       Date:  2001-02-15       Impact factor: 22.113

4.  Activation-induced cell death in peripheral blood mononuclear cells (PBMCs) from patients with chronic hepatitis B may be related to abnormal production of interleukin 12 and 10.

Authors:  W Ji; H F Wang; C Q Feng
Journal:  J Viral Hepat       Date:  2001-01       Impact factor: 3.728

5.  Fas/FasL-independent activation-induced cell death of T lymphocytes from HIV-infected individuals occurs without DNA fragmentation.

Authors:  S Kottilil; M I Bowmer; J Trahey; C Howley; J Gamberg; M D Grant
Journal:  Cell Immunol       Date:  2001-11-25       Impact factor: 4.868

6.  Selective up-regulation of phosphatidylinositol 3'-kinase activity in Th2 cells inhibits caspase-8 cleavage at the death-inducing complex: a mechanism for Th2 resistance from Fas-mediated apoptosis.

Authors:  A S Varadhachary; M E Peter; S N Perdow; P H Krammer; P Salgame
Journal:  J Immunol       Date:  1999-11-01       Impact factor: 5.422

7.  Murine acute graft-versus-host disease can be prevented by depletion of alloreactive T lymphocytes using activation-induced cell death.

Authors:  Udo F Hartwig; Michael Robbers; Claudia Wickenhauser; Christoph Huber
Journal:  Blood       Date:  2002-04-15       Impact factor: 22.113

Review 8.  Activation-induced cell death: the controversial role of Fas and Fas ligand in immune privilege and tumour counterattack.

Authors:  Stephen Maher; Deirdre Toomey; Claire Condron; David Bouchier-Hayes
Journal:  Immunol Cell Biol       Date:  2002-04       Impact factor: 5.126

9.  Proteasome inhibitors block Ras/ERK signaling pathway resulting in the downregulation of Fas ligand expression during activation-induced cell death in T cells.

Authors:  Yutaka Tanimoto; Harutoshi Kizaki
Journal:  J Biochem       Date:  2002-03       Impact factor: 3.387

10.  Circulating Th1 and Th2 cytokines in patients with hepatitis C virus infection.

Authors:  X G Fan; W E Liu; C Z Li; Z C Wang; L X Luo; D M Tan; G L Hu; Z Zhang
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

View more
  4 in total

1.  Relationship between genotypes and clinical manifestation, pathology, and cccDNA in Chinese children with hepatitis B virus-associated glomerulonephritis.

Authors:  Yong-Hong Sun; Xiao-Yan Lei; Yi-Pa Sai; Jun-Hui Chen; Yuan-Chun Sun; Xia Gao
Journal:  World J Pediatr       Date:  2016-04-08       Impact factor: 2.764

2.  Effect of viral load on T-lymphocyte failure in patients with chronic hepatitis B.

Authors:  Jing You; Hutcha Sriplung; Alan Geater; Virasakdi Chongsuvivatwong; Lin Zhuang; Hong-Ying Chen; Lan Yu; Bao-Zhang Tang; Jun-Hua Huang
Journal:  World J Gastroenterol       Date:  2008-02-21       Impact factor: 5.742

3.  Effect of SEN virus coinfection on outcome of lamivudine therapy in patients with hepatitis B.

Authors:  Dong Xu; De-Ying Tian; Zhen-Gang Zhang; Hong-Yun Chen; Pei-Hui Song
Journal:  World J Gastroenterol       Date:  2004-04-01       Impact factor: 5.742

4.  HBV cccDNA in patients' sera as an indicator for HBV reactivation and an early signal of liver damage.

Authors:  Ying Chen; Johnny Sze; Ming-Liang He
Journal:  World J Gastroenterol       Date:  2004-01       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.